(Q39430229)

English

Expressing human interleukin-15 from oncolytic vesicular stomatitis virus improves survival in a murine metastatic colon adenocarcinoma model through the enhancement of anti-tumor immunity.

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158521%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Expressing human interleukin-15 from oncolytic vesicular stomatitis virus improves survival in a murine metastatic colon adenocarcinoma model through the enhancement of anti-tumor immunity (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158521%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

oncolytic virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

colon adenocarcinoma

1 reference

based on heuristic

inferred from title

vesicular stomatitis

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158521%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

K B Stephenson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158521%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

N G Barra

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158521%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

E Davies

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158521%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

B D Lichty

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158521%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

9 December 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158521%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158521%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158521%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158521%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

238-246

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158521%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Navigating the clinical development landscape for oncolytic viruses and other cancer therapeutics: no shortcuts on the road to approval

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Recent progress in the battle between oncolytic viruses and tumours

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Oncolytic viruses: a novel form of immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Vesicular stomatitis virus: re-inventing the bullet

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Interference of CD40L-mediated tumor immunotherapy by oncolytic vesicular stomatitis virus.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Critical role for IL-15 in innate immunity

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

IL-15 transpresentation augments CD8+ T cell activation and is required for optimal recall responses by central memory CD8+ T cells.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Regression of subcutaneous B16 melanoma tumors after intratumoral delivery of an IL-15-expressing plasmid followed by in vivo electroporation

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

IL-15R -IgG1-Fc Enhances IL-2 and IL-15 Anti-tumor Action through NK and CD8+ T Cells Proliferation and Activation

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Immunotherapy: rAAV2 expressing interleukin-15 inhibits HeLa cell tumor growth in mice

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Myxoma virus expressing interleukin-15 fails to cause lethal myxomatosis in European rabbits.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

IL-15 has innate anti-tumor activity independent of NK and CD8 T cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Recombinant vesicular stomatitis viruses from DNA.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

High antitumor activity of RLI, an interleukin-15 (IL-15)-IL-15 receptor alpha fusion protein, in metastatic melanoma and colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Strategies to enhance viral penetration of solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Interleukin-12 expression enhances vesicular stomatitis virus oncolytic therapy in murine squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Expression of IFN-beta enhances both efficacy and safety of oncolytic vesicular stomatitis virus for therapy of mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

The IL-15/IL-15Ralpha on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Targeting tumor vasculature with an oncolytic virus

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

21 January 2018

Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

7 January 2021

based on heuristic

inferred from DOI database lookup

Requirement for CD4 T cell help in maintenance of memory CD8 T cell responses is epitope dependent

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

7 January 2021

based on heuristic

inferred from DOI database lookup

Transduction of murine colon carcinoma cells with interleukin-15 gene induces antitumor effects in immunocompetent and immunocompromised hosts

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.81

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39430229&oldid=2202874300"